advertisement

Topcon

Kolko M 32

Showing records 1 to 25 | Display all abstracts from Kolko M

106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Pasák M
Biomolecules 2022; 12:
106347 Optic disc drusen in patients diagnosed with normal tension glaucoma
Ahmadi H
Acta Ophthalmologica 2023; 101: 277-284
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Sperling S
Acta Ophthalmologica 2023; 101: 384-391
106813 Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review
Cvenkel B
Journal of clinical medicine 2022; 12:
106347 Optic disc drusen in patients diagnosed with normal tension glaucoma
Fotesko K
Acta Ophthalmologica 2023; 101: 277-284
106813 Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review
Kolko M
Journal of clinical medicine 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Stokholm L
Acta Ophthalmologica 2023; 101: 384-391
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Vanišová M; Tichotová L
Biomolecules 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Thykjaer AS
Acta Ophthalmologica 2023; 101: 384-391
106347 Optic disc drusen in patients diagnosed with normal tension glaucoma
Ba-Ali S; Hamann S
Acta Ophthalmologica 2023; 101: 277-284
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Křížová J
Biomolecules 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Pedersen FN
Acta Ophthalmologica 2023; 101: 384-391
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Ardan T
Biomolecules 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Möller S
Acta Ophthalmologica 2023; 101: 384-391
106347 Optic disc drusen in patients diagnosed with normal tension glaucoma
Kolko M
Acta Ophthalmologica 2023; 101: 277-284
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Laugesen CS
Acta Ophthalmologica 2023; 101: 384-391
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Nemesh Y; Čížková J
Biomolecules 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Andersen N; Andresen J
Acta Ophthalmologica 2023; 101: 384-391
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Kolesnikova A
Biomolecules 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Bek T
Acta Ophthalmologica 2023; 101: 384-391
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Nyshchuk R
Biomolecules 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
la Cour M
Acta Ophthalmologica 2023; 101: 384-391
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Josifovska N
Biomolecules 2022; 12:
106638 Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme
Hajari J
Acta Ophthalmologica 2023; 101: 384-391
106158 Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model
Lytvynchuk L; Kolko M
Biomolecules 2022; 12:

Issue 23-3

Change Issue


advertisement

Oculus